Unity Biotechnology, Inc. financial data

Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 22 Apr 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 301% % -33%
Debt-to-equity 320% % 122%
Return On Equity -274% % -105%
Return On Assets -65% % -19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17,212,172 shares 2.5%
Common Stock, Shares, Outstanding 17,212,172 shares 2.5%
Entity Public Float $22,509,406 USD -34%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 16,870,800 shares 0.51%
Weighted Average Number of Shares Outstanding, Diluted 16,870,800 shares 0.51%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $12,057,000 USD -33%
General and Administrative Expense $15,701,000 USD -13%
Operating Income (Loss) $30,463,000 USD 27%
Net Income (Loss) Attributable to Parent $27,502,000 USD 32%
Earnings Per Share, Basic -2 USD/shares 39%
Earnings Per Share, Diluted -2 USD/shares 39%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,999,000 USD 7.7%
Marketable Securities, Current $8,934,000 USD -69%
Assets, Current $17,647,000 USD -54%
Property, Plant and Equipment, Net $3,278,000 USD -32%
Operating Lease, Right-of-Use Asset $8,455,000 USD -32%
Other Assets, Noncurrent $71,000 USD -65%
Assets $30,347,000 USD -48%
Accounts Payable, Current $1,761,000 USD 26%
Accrued Liabilities, Current $6,064,000 USD 17%
Liabilities, Current $9,066,000 USD 17%
Operating Lease, Liability, Noncurrent $18,677,000 USD -17%
Liabilities $30,552,000 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,000 USD
Retained Earnings (Accumulated Deficit) $517,645,000 USD -5.6%
Stockholders' Equity Attributable to Parent $205,000 USD -101%
Liabilities and Equity $30,347,000 USD -48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $6,357,000 USD -23%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $6,776,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 17,212,172 shares 2.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $419,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,895,000 USD 6.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $117,850,000 USD 7.4%
Deferred Tax Assets, Gross $120,601,000 USD 6%
Operating Lease, Liability $22,607,000 USD -14%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $27,463,000 USD 32%
Lessee, Operating Lease, Liability, to be Paid $26,025,000 USD -16%
Property, Plant and Equipment, Gross $12,695,000 USD -11%
Operating Lease, Liability, Current $3,930,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,457,000 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,287,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,418,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,633,000 USD 3.2%
Deferred Tax Assets, Operating Loss Carryforwards $88,837,000 USD 9.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $17,490,000 USD 0.19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,801,000 USD 3%
Operating Lease, Payments $1,278,000 USD 3.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $178,000 USD -22%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $3,193,000 USD -52%
Interest Expense $1,450,000 USD -61%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%